Fresenius Kabi – Recall of fluphenazine decanoate injection
March 16, 2017 – Fresenius Kabi announced a user level recall of some lots of fluphenazine decanoate 25 mg/mL injection due to out-of-specification (OOS) results for a 13 month stability test of a specific lot. Additional lots may be OOS prior to expiry due to the common use of a supplier lot of active pharmaceutical ingredient.
Top